Catalyst Wire Dossier Catalyst Wire Dossier

zanuburutinib

zanuburutinib
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for zanuburutinib, covering 2021-02-09 to 2021-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Zanuburutinib in Relapsed and Refractory iMCD: a Prospective, Single-center, Single-arm Trial [Phase 2]

See pricing